Burford Brothers’s Teva Pharmaceuticals TEVA Stock Holding History

Burford Brothers’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.41M	Sell	146,370 -1,145	-0.8%	-$36.8K	1.81%	11
2025 Q4	$4.6M	Sell	147,515 -1,229	-0.8%	-$30.3K	1.9%	12
2025 Q3	$3M	Sell	148,744 -6,579	-4%	-$116K	1.28%	17
2025 Q2	$2.6M	Sell	155,323 -553	-0.4%	-$8.92K	1.19%	16
2025 Q1	$2.4M	Buy	155,876 +3,189	+2%	+$57K	1.16%	17
2024 Q4	$3.37M	Sell	152,687 -575	-0.4%	-$10.5K	1.65%	12
2024 Q3	$2.76M	Buy	153,262 +5,618	+4%	+$98.3K	1.44%	13
2024 Q2	$2.4M	Buy	147,644 +6,585	+5%	+$101K	1.39%	14
2024 Q1	$1.99M	Buy	141,059 +1,360	+1%	+$17.1K	1.31%	15
2023 Q4	$1.46M	Buy	+139,699	New	+$1.3M	1.03%	23

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Burford Brothers's TEVA Position: Q1 2026 in Review

Burford Brothers reduced its Teva Pharmaceuticals (TEVA) stake by 0.78% in Q1 2026, selling an estimated $36.8K and leaving 146,370 shares worth $4.41M. The position accounts for 1.81% of the portfolio, ranked #11.

Burford Brothers first reported a position in TEVA in Q4 2023 and has held it in 10 quarters since. The position peaked at $4.6M in Q4 2025. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

Burford Brothers held 146,370 shares of Teva Pharmaceuticals worth $4.41M as of Q1 2026.
Burford Brothers sold 1,145 Teva Pharmaceuticals shares in Q1 2026, an estimated $36.8K.
Teva Pharmaceuticals made up 1.81% of Burford Brothers's portfolio in Q1 2026, its #11 holding.
Burford Brothers first reported a position in Teva Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
Burford Brothers's Teva Pharmaceuticals position peaked at $4.6M in Q4 2025.
650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Burford Brothers's 13F filing for Q1 2026, filed 27 Apr 2026.